FDA approves first immunotherapy regimen for breast cancer

The US Food and Drug Administration has granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday. (CNN Photo)

The US Food and Drug Administration has granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday.

Posted: Mar 9, 2019 10:17 AM

(CNN) -- The US Food and Drug Administration has granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday.

The treatment received accelerated approval for triple-negative breast cancer that is locally advanced or metastatic, that cannot be surgically removed and whose cells include a protein called PD-L1. It comprises a combination of immunotherapy and chemotherapy: Tecentriq and Abraxane, respectively.

The FDA's decision comes after an October study published in the New England Journal of Medicine found that the therapy extended progression-free survival -- the amount of time in which a patient's cancer does not worsen. In the PD-L1 subgroup, the median progression-free survival for those receiving the combination treatment was 7.4 months, versus 4.8 months for those getting the chemotherapy with placebo, according to the FDA's announcement. The trial was funded by Genentech Inc., the maker of Tecentriq.

"This is the first time immunotherapy has worked in such a difficult to treat cancer, and is a huge step forward for these breast cancer patients," lead study author Dr. Peter Schmid of Queen Mary University of London said in an October statement.

Dr. Otis Brawley, Bloomberg Distinguished Professor of oncology and epidemiology at Johns Hopkins University, said the FDA's decision to grant the treatment accelerated approval was "the right thing to do" but cautioned that it's not the end of the story.

"The FDA has approved it based on progression-free survival with the hope that later on ... data will show that the treatment actually makes women live longer," said Brawley, who was not involved in researching the treatment.

This FDA says it grants accelerated approvals to "drugs that treat serious conditions, and that fill an unmet medical need" based on data that suggests, but may not directly measure, a clinical benefit. Drugmakers are still required to confirm that the drug is beneficial through later trials. If that happens, the drug may receive a traditional FDA approval. Otherwise, the agency may decide to pull the drug, as has happened in the past.

In this case, the drugmaker is expected to submit a final report detailing subsequent findings in September 2020, according to the approval letter from the FDA to Genentech.

Tecentriq, the brand name of the immunotherapy drug atezolizumab, was previously approved to treat other specific types of urinary and lung cancers.

Breast cancer patients on the newly approved therapy most commonly reported adverse reactions like hair loss, fatigue, nausea, headaches and decreased appetites, according to the FDA.

Dr. Larry Norton, director of the Evelyn H. Lauder Breast Center at Memorial Sloan Kettering Cancer Center, told CNN in October that scientists are learning "so much and so rapidly about other ways to stimulate the immune system" that he predicts an "explosion of well-designed studies that will push the agenda forward."

Norton, who was not involved in the October study, said "this is just the beginning of using immunotherapy for breast cancer."

Triple-negative breast cancer
About 15% of breast cancers are triple-negative, according to the National Breast Cancer Foundation. The protein PD-L1 may be found in roughly a fifth of those cancers, research has shown.

Triple-negative breast cancer is most likely to affect Hispanic and African-American women and those with a BRCA1 gene mutation. It also tends to appear among women in their 40s and 50s.

"It is particularly tragic that those affected are often young," Queen Mary University's Schmid said. "We have desperately been looking for better treatment options."

When breast cancer cells test negative for estrogen, progesterone or human epidermal growth factor 2 (HER2), it's called a triple-negative breast cancer. Therefore, it does not respond to any of the available hormonal cancer treatments.

It does respond to chemotherapy. However, cancer cells can quickly develop resistance to chemo drugs, allowing them to spread to other parts of the body, reducing survival rates.

How does it work?
Cancers have a way of eluding the body's immune system, which recognizes them as part of the body. That's where Tecentriq comes in: It's an antibody that attaches to the cancer cell and inactivates the PD-L1 protein, which is responsible for telling the immune system, "don't attack me."

Chemotherapy is also needed to "rough up" the exterior of the cancer cell, Schmid explained. That allows the newly revved-up immune system to recognize and attack the invader.

"We are using chemotherapy to tear away the tumor's 'immune-protective cloak,' to expose it," Schmid said, "enabling people's own immune system to get at it."

Norton said in October that "I think the expectation is, this will change the standard of care.

"This is a real advance that is going to allow us to help more people."

Terre Haute
Partly Cloudy
85° wxIcon
Hi: 89° Lo: 73°
Feels Like: 93°
Robinson
Partly Cloudy
83° wxIcon
Hi: 90° Lo: 72°
Feels Like: 98°
Indianapolis
Mostly Cloudy
85° wxIcon
Hi: 89° Lo: 74°
Feels Like: 93°
Rockville
Partly Cloudy
82° wxIcon
Hi: 88° Lo: 74°
Feels Like: 93°
Casey
Partly Cloudy
84° wxIcon
Hi: 88° Lo: 74°
Feels Like: 94°
Brazil
Partly Cloudy
85° wxIcon
Hi: 89° Lo: 73°
Feels Like: 93°
Marshall
Partly Cloudy
85° wxIcon
Hi: 88° Lo: 72°
Feels Like: 93°
Scattered storms with heavy rain possible
WTHI Planner
WTHI Temps
WTHI Radar

WTHI Events

 

Illinois Coronavirus Cases

(Widget updates once daily at 7 p.m. CT)

Cases: 1415572

Reported Deaths: 25853
CountyCasesDeaths
Cook56308410559
DuPage937531321
Will781251042
Lake692061027
Kane60105816
Winnebago34719524
Madison32433533
St. Clair30073526
McHenry29590299
Peoria23726346
Champaign21601158
Sangamon19672245
McLean18864194
Tazewell17508308
Rock Island15398329
Kankakee14754224
Kendall1349999
LaSalle12968254
Macon11193215
DeKalb10286122
Vermilion10247154
Adams9635128
Williamson8165138
Whiteside7249174
Boone694280
Ogle629884
Grundy605879
Clinton591993
Coles5872101
Knox5735157
Jackson546465
Henry516070
Macoupin498790
Livingston494394
Woodford492683
Stephenson488186
Franklin487879
Effingham483274
Marion4782118
Jefferson4668123
Monroe452394
Randolph432587
Lee424054
Morgan413793
Fulton410959
Logan407366
Christian394875
Bureau386187
Montgomery385274
Iroquois330168
Perry328662
Fayette326856
McDonough305751
Jersey279552
Saline272057
Douglas263736
Union250241
Lawrence245027
Shelby236138
Crawford219026
Bond213624
Cass210727
Carroll204937
Pike201453
Ford194950
Hancock194132
Clark190734
Wayne190153
Warren186750
Jo Daviess183524
Richland181740
White180626
Edgar179842
Washington169625
Moultrie168128
Mason164247
De Witt161429
Piatt156314
Johnson155416
Clay155043
Greene153534
Mercer152434
Wabash148612
Massac143740
Cumberland131119
Menard128412
Jasper116918
Marshall110819
Hamilton90316
Schuyler8147
Brown8116
Pulaski7437
Stark66425
Edwards63612
Calhoun5422
Henderson53414
Gallatin5064
Scott5051
Putnam4943
Alexander48911
Hardin39612
Pope3404
Unassigned662433
Out of IL150

Indiana Coronavirus Cases

(Widget updates once daily at 8 p.m. ET)

Cases: 768624

Reported Deaths: 13993
CountyCasesDeaths
Marion1055891807
Lake569801031
Allen43032699
St. Joseph37344568
Hamilton37335426
Elkhart29783470
Tippecanoe23503230
Vanderburgh23240405
Porter19580327
Johnson18843392
Hendricks18089323
Madison13575347
Clark13552198
Vigo12869256
LaPorte12578225
Monroe12575178
Delaware11155198
Howard10693237
Kosciusko9792124
Hancock8761150
Bartholomew8274157
Warrick8084157
Floyd8043182
Grant7378181
Wayne7239201
Boone7211105
Morgan6924143
Marshall6345117
Dubois6283118
Cass6096112
Dearborn602178
Noble600890
Henry5958111
Jackson517277
Shelby511598
Lawrence4928127
Gibson463696
Montgomery459292
DeKalb456785
Clinton456055
Harrison454077
Huntington417882
Whitley416745
Steuben411260
Miami406073
Jasper401655
Knox388691
Putnam385762
Wabash370384
Adams353856
Ripley351971
Jefferson343487
White340154
Daviess3089100
Wells304081
Greene295185
Decatur292693
Fayette286564
Posey282635
Scott281058
LaGrange277772
Clay274949
Washington254637
Randolph247783
Jennings239749
Spencer238731
Fountain235850
Starke229959
Owen222959
Sullivan221643
Fulton208945
Jay203032
Carroll197722
Orange191756
Perry189939
Vermillion181144
Rush177627
Tipton173347
Franklin172535
Parke155916
Pike142534
Blackford138032
Pulaski123748
Newton123336
Benton109715
Brown106243
Crawford105816
Martin92515
Warren87915
Switzerland8378
Union73610
Ohio58411
Unassigned0429